Delivery Order SPE2DB22D3004-SPE2DB25FSH08
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Feraheme 510 mg/17 mL vials valued at $2,749.40. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $6,396.31 firm fixed-price contract is for the delivery of Feraheme 510 mg/17 ml vials, a medication used to treat iron deficiency anemia. The award has an ultimate completion date of August 30, 2023 and was issued on August 29, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Feraheme, a 510 mg/17 ml vial of an iron replacement product, with a ceiling value of $4,046.77 and a period of performance through May 1, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Feraheme 510 mg/17 ml vials, a specialty pharmaceutical product. The delivery order has a ceiling value of $12,478.46 and a performance period through April 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Feraheme, a 510 mg/17 ml iron replacement injection product. The order has a ceiling value of $2,993.60 and a performance period through March 28, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that DLA awarded solely to...
- This is a $4,127.60 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Feraheme 510 mg/17 ml vials, a medical product used for the treatment of iron deficiency anemia. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a 510 mg/17 ml vial medication, with a ceiling value of $2,652.49 and a performance period extending through April 23, 2025. The contract is not set aside and was awarded on April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,160.30, is for the delivery of Feraheme 510 mg/17 ml vials, a medication used to treat iron deficiency anemia. The contract is a firm fixed-price delivery order with a completion date of December 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH08Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,598.26 to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 mL vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Feraheme is an iron replacement therapeutic used in medical treatment, and this delivery order fulfills a specific medical supply need within the Defense Logistics Agency's pharmaceutical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026. As the prime contractor on this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's role as a major pharmaceutical distributor positions it as a critical vendor for federal medical procurement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle that enables rapid fulfillment of urgent medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 9/4/25 |